HRP20171567T1 - Supstituirani 2-alkil-1-okso-n-fenil-3-heteroaril-1,2,3,4-tetrahidroizohinolin-4-karboksamidi za antimalarijske terapije - Google Patents
Supstituirani 2-alkil-1-okso-n-fenil-3-heteroaril-1,2,3,4-tetrahidroizohinolin-4-karboksamidi za antimalarijske terapije Download PDFInfo
- Publication number
- HRP20171567T1 HRP20171567T1 HRP20171567TT HRP20171567T HRP20171567T1 HR P20171567 T1 HRP20171567 T1 HR P20171567T1 HR P20171567T T HRP20171567T T HR P20171567TT HR P20171567 T HRP20171567 T HR P20171567T HR P20171567 T1 HRP20171567 T1 HR P20171567T1
- Authority
- HR
- Croatia
- Prior art keywords
- oxo
- tetrahydroisoquinoline
- carboxamide
- pyrazol
- isobutyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161527594P | 2011-08-25 | 2011-08-25 | |
| PCT/IB2012/054305 WO2013027196A1 (en) | 2011-08-25 | 2012-08-24 | Substituted 2-alkyl-1-oxo-n-phenyl-3-heteroaryl-1,2,3,4- tetrahydroisoquinoline-4-carboxamides for antimalarial therapies |
| EP12772470.6A EP2748147B1 (en) | 2011-08-25 | 2012-08-24 | Substituted 2-alkyl-1-oxo-n-phenyl-3-heteroaryl-1,2,3,4-tetrahydroisoquinoline-4-carboxamides for antimalarial therapies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20171567T1 true HRP20171567T1 (hr) | 2017-11-17 |
Family
ID=47018313
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20171567TT HRP20171567T1 (hr) | 2011-08-25 | 2012-08-24 | Supstituirani 2-alkil-1-okso-n-fenil-3-heteroaril-1,2,3,4-tetrahidroizohinolin-4-karboksamidi za antimalarijske terapije |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US9416124B2 (enExample) |
| EP (1) | EP2748147B1 (enExample) |
| JP (1) | JP6035334B2 (enExample) |
| CN (1) | CN103930404B (enExample) |
| BR (1) | BR112014004437B1 (enExample) |
| CA (1) | CA2846507C (enExample) |
| CY (1) | CY1119748T1 (enExample) |
| DK (1) | DK2748147T3 (enExample) |
| ES (1) | ES2644082T3 (enExample) |
| HR (1) | HRP20171567T1 (enExample) |
| HU (1) | HUE034721T2 (enExample) |
| LT (1) | LT2748147T (enExample) |
| ME (1) | ME02908B (enExample) |
| PL (1) | PL2748147T3 (enExample) |
| PT (1) | PT2748147T (enExample) |
| RS (1) | RS56544B1 (enExample) |
| SI (1) | SI2748147T1 (enExample) |
| SM (1) | SMT201700528T1 (enExample) |
| WO (1) | WO2013027196A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111886225A (zh) * | 2017-08-21 | 2020-11-03 | 纳维根公司 | Arf6抑制剂及相关方法 |
| EP3892332A1 (en) | 2020-04-09 | 2021-10-13 | University Of Kentucky Research Foundation | New anti-malarial agents |
| CA3214899A1 (en) | 2021-04-15 | 2022-10-20 | Lutz Weber | Isoquinoline derivatives for use as antiviral and antitumour agents |
| EP4074314A1 (en) | 2021-04-15 | 2022-10-19 | Valdospan GmbH | Isoquinoline derivatives for use as antiviral and antitumour agents |
| AU2023363824A1 (en) | 2022-10-17 | 2025-04-17 | Rdp Pharma Ag | Isoquinoline derivatives as protein degraders, e7 degraders, antivirals, tumor therapeutics and immune suppressives |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5409938A (en) * | 1994-02-14 | 1995-04-25 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Antimalarial korupensamines and pharmaceutical compositions and medical uses thereof |
| US5639761A (en) * | 1994-02-14 | 1997-06-17 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Antimalarial naphthylisoquinoline alkaloids and pharmaceutical compositions and medical uses thereof |
| US6921762B2 (en) * | 2001-11-16 | 2005-07-26 | Amgen Inc. | Substituted indolizine-like compounds and methods of use |
| WO2004004727A1 (en) | 2002-07-03 | 2004-01-15 | Axys Pharmaceuticals, Inc. | 3,4-dihydroisoquinolin-1-one derivatives as inducers of apoptosis |
| DE10237722A1 (de) * | 2002-08-17 | 2004-08-19 | Aventis Pharma Deutschland Gmbh | Indol- oder Benzimidazolderivate zur Modulation der IKappaB-Kinase |
| DE10312963A1 (de) | 2003-03-24 | 2004-10-07 | Aventis Pharma Deutschland Gmbh | Substituierte 4-Phenyltetrahydroisochinoline, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament |
| UY29440A1 (es) * | 2005-03-25 | 2006-10-02 | Glaxo Group Ltd | Nuevos compuestos |
| RU2302417C1 (ru) * | 2006-03-14 | 2007-07-10 | Иващенко Андрей Александрович | 1-оксо-3-(1н-индол-3-ил)-1,2,3,4-тетрагидроизохинолины, способы их получения, комбинаторная библиотека и фокусированная библиотека |
| BRPI0912871A2 (pt) * | 2008-05-19 | 2015-10-20 | Actelion Pharmaceuticals Ltd | novas tetraidroisoquinolinas como agentes antimaláricos. |
| GB0820856D0 (en) | 2008-11-14 | 2008-12-24 | Univ Leuven Kath | Novel inhibitors of flavivirus replication |
-
2012
- 2012-08-24 DK DK12772470.6T patent/DK2748147T3/da active
- 2012-08-24 CN CN201280041436.4A patent/CN103930404B/zh active Active
- 2012-08-24 HR HRP20171567TT patent/HRP20171567T1/hr unknown
- 2012-08-24 HU HUE12772470A patent/HUE034721T2/hu unknown
- 2012-08-24 LT LTEP12772470.6T patent/LT2748147T/lt unknown
- 2012-08-24 SM SM20170528T patent/SMT201700528T1/it unknown
- 2012-08-24 PT PT127724706T patent/PT2748147T/pt unknown
- 2012-08-24 BR BR112014004437-6A patent/BR112014004437B1/pt active IP Right Grant
- 2012-08-24 ME MEP-2017-250A patent/ME02908B/me unknown
- 2012-08-24 JP JP2014526594A patent/JP6035334B2/ja not_active Expired - Fee Related
- 2012-08-24 CA CA2846507A patent/CA2846507C/en active Active
- 2012-08-24 PL PL12772470T patent/PL2748147T3/pl unknown
- 2012-08-24 US US14/240,994 patent/US9416124B2/en active Active
- 2012-08-24 RS RS20171090A patent/RS56544B1/sr unknown
- 2012-08-24 ES ES12772470.6T patent/ES2644082T3/es active Active
- 2012-08-24 SI SI201231080T patent/SI2748147T1/sl unknown
- 2012-08-24 EP EP12772470.6A patent/EP2748147B1/en active Active
- 2012-08-24 WO PCT/IB2012/054305 patent/WO2013027196A1/en not_active Ceased
-
2017
- 2017-10-20 CY CY20171101092T patent/CY1119748T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR112014004437A8 (pt) | 2018-01-23 |
| CN103930404A (zh) | 2014-07-16 |
| BR112014004437B1 (pt) | 2021-12-14 |
| ME02908B (me) | 2018-10-20 |
| RS56544B1 (sr) | 2018-02-28 |
| US20140235593A1 (en) | 2014-08-21 |
| CN103930404B (zh) | 2016-08-24 |
| BR112014004437A2 (pt) | 2017-03-28 |
| HUE034721T2 (hu) | 2018-02-28 |
| SMT201700528T1 (it) | 2018-01-11 |
| DK2748147T3 (da) | 2017-11-13 |
| EP2748147B1 (en) | 2017-08-02 |
| EP2748147A1 (en) | 2014-07-02 |
| ES2644082T3 (es) | 2017-11-27 |
| PT2748147T (pt) | 2017-11-14 |
| US9416124B2 (en) | 2016-08-16 |
| WO2013027196A9 (en) | 2013-04-18 |
| JP6035334B2 (ja) | 2016-11-30 |
| WO2013027196A1 (en) | 2013-02-28 |
| LT2748147T (lt) | 2017-10-25 |
| JP2014524464A (ja) | 2014-09-22 |
| PL2748147T3 (pl) | 2018-01-31 |
| HK1199443A1 (en) | 2015-07-03 |
| CA2846507A1 (en) | 2013-02-28 |
| CA2846507C (en) | 2020-03-10 |
| CY1119748T1 (el) | 2018-06-27 |
| SI2748147T1 (sl) | 2017-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102148237B1 (ko) | 융합 바이사이클릭 설파모일 유도체 및 b형 간염 치료제로서의 그 용도 | |
| AU2012382875B2 (en) | Compound as WNT signaling inhibitor, composition, and use thereof | |
| CA2647116C (en) | Imidazo [1, 2-b] pyridazines, their processes of preparation and their use as gaba receptor ligands | |
| CN102869661B (zh) | 抗感染化合物 | |
| JP6236068B2 (ja) | ＲＯＲγ活性を阻害し疾患を治療するためのテトラヒドロナフチリジンおよび関連二環式化合物 | |
| ES2629389T3 (es) | 2-fenilimidazo[1,2-a]pirimidinas como agentes de obtención de imágenes | |
| RU2240322C2 (ru) | Производные нафтиридина и содержащая их фармацевтическая композиция | |
| CA2395717C (en) | Fused imidazolium derivatives | |
| CA2989722C (en) | Pyrazolo[1,5-a]triazin-4-amine derivatives useful in therapy | |
| HRP20171567T1 (hr) | Supstituirani 2-alkil-1-okso-n-fenil-3-heteroaril-1,2,3,4-tetrahidroizohinolin-4-karboksamidi za antimalarijske terapije | |
| JP2014514360A5 (enExample) | ||
| HRP20160396T1 (hr) | Novi kiralni n-acil-5,6,7(8-susupstituirani)-tetrahidro-/1,2,4/triazolo/4,3-a/pirazini kao selektivni nk-3 receptor antagonisti, farmaceutski pripravak, i metode za upor | |
| JP2014037426A5 (enExample) | ||
| RU2010117156A (ru) | Гетероциклические соединения в качестве антагонистов crth2 рецептора | |
| JP6893516B2 (ja) | ３−（（ヘテロ−）アリール）−８−アミノ−２−オキソ−１，３−ジアザ−スピロ−［４．５］−デカン誘導体 | |
| HRP20170695T1 (hr) | Fenil-3-aza-biciklo[3.1.0]heks-3-il-metanoni i njihova uporaba u obliku lijeka | |
| TW202039446A (zh) | 雜環化合物 | |
| ES2650921T3 (es) | Compuestos tricíclicos de imidazol como inhibidores de hidroxilasa de triptófano | |
| JP2014524464A5 (enExample) | ||
| KR20070029661A (ko) | 헤테로사이클릭 ｇａｂａ-ａ 아형 선택적 수용체 조절제 | |
| RU2014127984A (ru) | Хинолиновые производные как ингибиторы фермента pde10a | |
| CA2635802A1 (en) | Imidazo (1,2-a)pyridin-3-yl-acetic acid hydrazides, processes for their preparation and pharmaceutical uses thereof | |
| JPWO2021001453A5 (enExample) | ||
| JPWO2021204952A5 (enExample) |